Gene expression analysis of Tek/Tie2 signaling

Physiological Genomics

Volumn 22, Issue , 2005, Pages 257-267

  Chen, Stephen H ^a,b   Babichev, Yael ^a   Rodrigues, Natalie ^a   Voskas, Daniel ^a,b   Ling, Ling ^a,b   Nguyen, Vicky P K H ^a,b   Dumont, Daniel J ^a,b,c  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Angiogenesis; Receptor tyrosine kinase; Serial analysis of gene expression

Indexed keywords

ANGIOPOIETIN RECEPTOR; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK3; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CAPILLARY; DNA LIBRARY; EMBRYO; EMBRYO DEATH; EMBRYO DEVELOPMENT; EXTRACTION; GENE EXPRESSION REGULATION; GENE SWITCHING; GENE TARGETING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; VASCULARIZATION; WILD TYPE;

ANIMALS; EMBRYO; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; RECEPTOR, TIE-2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 25144438457     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00063.2005     Document Type: Article

References (50)

1. Abu El-Asrar AM, Meersschaert A, Dralands L, Missotten L, and Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 18: 306-313, 2004.
2. Adams RH and Klein R. Eph receptors and ephrin ligands. essential mediators of vascular development. Trends Cardiovasc Med 10: 183-188, 2001.
3. Ayadi A, Suelves M, Dolle P, and Wasylyk B. Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech Dev 102: 205-208, 2001.
4. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, Alitalo K, and Wasylyk B. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J 20: 5139-5152, 2001.
5. Babaei S, Teichert-Kuliszewska K, Zhang Q, Jones N, Dumont DJ, and Stewart DJ. Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am J Pathol 162: 1927-1936, 2003.
6. Baross A, Schertzer M, Zuyderduyn SD, Jones SJ, Marra MA, and Lansdorp PM. Effect of TERT and ATM on gene expression profiles in human fibroblasts. Genes Chromosomes Cancer 39: 298-310, 2004.
7. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, and Edgar R. NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res 33 (Database issue): D562-D566, 2005.
8. Betsholtz C, Karlsson L, and Lindahl P. Developmental roles of platelet-derived growth factors. Bioassays 23: 494-507, 2001.
9. Breier G. Angiogenesis in embryonic development-a review. Placenta 21, Suppl 1: S11-S15, 2000.
10. Breier G, Albrecht U, Sterrer S, and Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114: 521-532, 1992.
11. Carmeiiet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395, 2000.
12. Chen JX, Lawrence ML, Cunningham G, Christman BW, and Meyrick B. HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium. J Appl Physiol 96: 612-620, 2004.
13. Chen YH, Layne MD, Chung SW, Ejima K, Baron RM, Yet SF, and Perrella MA. Elk-3 is a transcriptional repressor of nitric-oxide synthase 2. J Biol Chem 278: 39572-39577, 2003.
14. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, and Yancopoulos GD. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87: 1161-1169, 1996.
15. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, and Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992.
16. Dimmeler S, Haendeler J, Nehls M, and Zeiher AM. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med 185: 601-607, 1997.
17. Dumont DJ, Gradwohl G, Fong GH, Pun MC, Gertsenstein M, Auerbach A, and Breitman ML. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8: 1897-1909, 1994.
18. Giovane A, Pintzas A, Maira SM, Sobieszczuk P, and Wasylyk B. Net, a new ets transcription factor that is activated by Ras. Genes Dev 8: 1502-1513, 1994.
19. Homma H, Takahashi T, Seki H, Ohtani M, Kondoh T, and Fukuda M. Immunohistochemical localization of inducible nitric oxide synthase in synovial tissue of human temporomandibular joints with internal derangement. Arch Oral Biol 46: 93-97, 2001.
20. Jones N, Iljin K, Dumont DJ, and Alitalo K. Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2: 257-267, 2001.
21. Jones N, Master Z, Jones J, Bouchard D, Gunji Y, Sasaki H, Daly R, Alitalo K, and Dumont DJ. Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration. J Biol Chem 274: 30896-30905, 1999.
22. Jones N, Voskas D, Master Z, Sarao R, Jones J, and Dumont DJ. Rescue of the early vascular defects in Tek/Tie2 null mice reveals an essential survival function. EMBO Rep 2: 438-445, 2001.
23. Jones PF. Not just angiogenesis-wider roles for the angiopoietins. J Pathol 201: 515-527, 2003.
24. Kingsley PD, Malik J, Fantauzzo KA, and Palis J. Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis. Blood 104: 19-25, 2004.
25. Kontos CD, Stauffer TP, Yang WP, York JD, Huang L, Blanar MA, Meyer T, and Peters KG. Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18: 4131-4140, 1998.
26. Lash AE, Tolstoshev CM, Wagner L, Schuler GD, Strausberg RL, Riggins GJ, and Altschul SF. SAGEmap: a public gene expression resource. Genome Res 10: 1051-1060, 2000.
27. Leung SK and Ohh M. Playing Tag with HIF: The VHL Story. J Biomed Biotechnol 2: 131-135, 2002.
28. Li J, Billiar TR, Talanian RV, and Kim YM. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240: 419-424, 1997.
29. Lofstedt T, Jogi A, Sigvardsson M, Gradin K, Poellinger L, Pahlman S, and Axelson H. Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 279: 39223-39231, 2004.
30. Mungrue IN, Bredt DS, Stewart DJ, and Husain M. From molecules to mammals: what's NOS got to do with it? Acta Physiol Scand 179: 123-135, 2003.
31. Mungrue IN, Husain M, and Stewart DJ. The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev 7: 407-422, 2002.
32. Nath AK, Enciso J, Kuniyasu M, Hao XY, Madri JA, and Pinter E. Nitric oxide modulates murine yolk sac vasculogenesis and rescues glucose induced vasculopathy. Development Disease 131: 2485-2496, 2004.
33. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, and Sessa WC. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79: 213-223, 1999.
34. Patan S. Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 50: 1-15, 2000.
35. Risau W. Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
36. Risau W and Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 11: 73-91, 1995.
37. Rossig L, Fichtlscherer B, Breitschopf K, Haendeler J, Zeiher AM, Mulsch A, and Dimmeler S. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem 274: 6823-6826, 1999.
38. Rozen S and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology, edited by Krawetz S and Misener S. Totowa, NJ: Humana, 2000, p. 365-386.
39. Ruijter JM, Van Kampen AH, and Baas F. Statistical evaluation of SAGE libraries: consequences for experimental design. Physiol Genomics 11: 37-44, 2002.
40. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, and Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74, 1995.
41. Schwarz F, Duka A, Triantafyllidi E, Johns C, Duka I, Cui J, and Gavras H. Serial analysis of gene expression in mouse kidney following angiotensin II administration. Physiol Genomics 16: 90-98, 2003.
42. Tait CR and Jones PF. Angiopoietins in tumours: the angiogenic switch. J Pathol 204: 1-10, 2004.
43. Veikkola T and Alitalo K. VEGFs, receptors and angiogenesis. Semin Cancer Biol 9: 211-220, 1999.
44. Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW. Serial analysis of gene expression. Science 270: 484-487, 1995.
45. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, Lal A, Wang CJ, Beaudry GA, Ciriello KM, Cook BP, Dufault MR, Ferguson AT, Gao Y, He TC, Hermeking H, Hiraldo SK, Hwang PM, Lopez MA, Luderer HF, Mathews B, Petroziello JM, Polyak K, Zawel L, Zang W, Zang X, Zhou W, Haluska FG, Jen J, Sukumar S, Landes GM, Riggins GR, Vogelstein B, and Kinzler KW. Analysis of human transcriptomes. Nat Genet 23: 387-388, 1999.
46. Ward NL and Dumont DJ. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin Cell Dev Biol 13: 19-27, 2002.
47. Wilting J and Christ B. Embryonic angiogenesis: a review. Naturwissenschaften 83: 153-164, 1996.
48. Yamakawa H, Jezova M, Ando H, and Saavedra JM. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23: 371-380, 2003.
49. Zhang B, Schmoyer D, Kirov S, and Snoddy J. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies. BMC Bioinformatics 5: 16, 2004.
50. Zheng H, Wasylyk C, Ayadi A, Abecassis J, Schalken JA, Rogatsch H, Wernert N, Maira SM, Multon MC, and Wasylyk B. The transcription factor Net regulates the angiogenic switch. Genes Dev 17: 2283-2297, 2003.